| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Malley Thomas is a Director at Tempest Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 3 sells.
Estimated insider holdings value: $20.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 177,769 | $32.96 | $5,859,815.05 | -82.5% | +21.9% | - | |
| Jun 16, 2023 | KURA Kura Oncology, Inc. | Director | Buy | 50,000 | $11.50 | $575,000.00 | +55.8% | -9.9% | +93.5% | |
| Nov 10, 2015 | KURA Kura Oncology, Inc. | Director | Buy | 50,000 | $8.00 | $400,000.00 | +126.4% | - | - | |
| Apr 8, 2015 | TPST Tempest Therapeutics, Inc. | Director | Buy | 5,000 | $28.50 | $142,500.00 | +4.3% | - | - | |
| Jan 13, 2015 | TPST Tempest Therapeutics, Inc. | Director | Buy | 35,000 | $50.00 | $1,750,000.00 | +42.8% | - | - |